The central opioid system in liver disease and its complications

Metabolic Brain Disease

Volumn 16, Issue 1-2, 2001, Pages 79-83

  Yurdaydin, Cihan ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Cholestasis; Fatigue; Hepatic encephalopathy; Opioids

Indexed keywords

OPIATE; OPIATE RECEPTOR;

BRAIN FUNCTION; CHOLESTATIC HEPATITIS; DISEASE ASSOCIATION; DISEASE COURSE; FATIGUE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER DISEASE; NEUROTRANSMISSION; PATHOGENESIS; PRURITUS; SHORT SURVEY;

FATIGUE; HEPATIC ENCEPHALOPATHY; HUMANS; OPIOID PEPTIDES;

EID: 0035172044     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011618729660     Document Type: Short Survey

References (36)

1. The pathogenesis and treatment of hepatic encephalopathy: Evidence for the involvement of benzodiazepine receptor ligands
2. Effects of naloxone infusions in patients with the pruritis of cholestasis: A double-blind, randomized, controlled trial
3. Cholestasis in the male rat is associated with naloxone-reversible antinociception
4. Plasma from patients with the pruritis of cholestasis induces opioid receptor-mediated scratching in monkeys
5. Relief of intractable pmritis with naloxone
6. Naloxone-induced inhibition of ethanol dependence in mice
7. Hepatic encephalopathy: Disorder of multiple neurotransmitter systems
8. Combination treatment of hepatic encephalopathy due to thioacetamide-induced fulminant hepatic failure in the rat with benzodiazepine and opioid receptor antagonists
9. Portacaval anastomosis induces region-selective alterations of the endogenous opioid system in the rat brain
10. Does hepatitis C infection affect the brain? A proton magnetic resonance study
11. Enkephalin-induced depression of single neurons in brain areas with opiate receptors - Antagonism by naloxone
12. Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference
13. Comparison of the effects of GABA and enkephalin on synaptically evoked activity in the rat striatum
14. International Union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin)
15. Patients with primary biliary cirrhosis have central but no peripheral fatigue
16. Fatigue associated with chronic liver disease: A riddle wrapped in a mystery inside an enigma
17. Relief from profound fatigue associated with chronic liver disease by long-term ondansetron therapy
18. Florid opioid withdrawal-like reaction precipitated by naltrexone in a patient with chronic cholestasis
19. The pruritis of cholestasis
20. Is fatigue associated with cholestasis mediated by altered central neurotransmission?
21. Sickness behavior as a new target for drug development
22. Morphine tolerance in hepatic cirrhosis
23. Increased ethanol consumption and blood ethanol levels in rats with portacaval shunts
24. Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritis in internal and dermatological diseases
25. The endocrinology of the opioids
26. Renal itch
27. Naloxone in hepatic encephalopathy
28. Voluntary ethanol consumption of alcohol in rats with cirrhosis of the liver
29. Improvement in cholestasis-associated fatigue with a serotonin receptor antagonist using a novel rat model of fatigue assessment
30. Viral hepatitis A through G
31. Opioid peptides and primary biliary cirrhosis
32. Methionine enkephalin is increased in plasma in acute liver disease and is present in bile and urine
33. Evidence for a possible role of 5-hydroxytryptamine in the genesis of fatigue in man: Administration of paroxetine, a 5-HT reuptake inhibitor, reduces the capacity to perform prolonged exercise
34. Oral naltrexone treatment for choestatic pruritis: A double-blind, placebo-controlled study
35. Opioid receptor ligands in human hepatic encephalopathy
36. Brain and plasma levels of opioid peptides and altered in rats with thioacetamide-induced fulminant hepatic failure: Implications for the treatment of hepatic encephalopathy with opioid antagonists